VIDEO ON MSN MONEY
These funds target the auto industry, which has performed well despite macroeconomic headwinds.
By Don Dion, TheStreet
While the sour start to the month may be enough to drive some investors back toward havens, I encourage them to avoid shunning the markets entirely.
Predicting the next big thing among youths is nearly impossible, but choosing good investments in the teen-retail sector doesn't have to be as difficult.
By Lindsey Bell, TheStreet
The back-to-school season was a success for most retailers, a sign finicky teens are still spending. But which clothing and accessories retailers are worth investing in?
Despite teenage unemployment at a staggering 24% (compared with the national average of 9.1%) and rising prices, young people are willing to spend on new, must-have things like denim jeans and phones.
Once a supposed blockbuster, Provenge costs a whopping $93,000 per treatment, but its effectiveness has been called into question.
By Barry Cohen, InvestorPlace.com
Dendreon (DNDN) was getting ripped apart Thursday with a 35% loss in intraday trading. The reason for the biotech company's woes is a report that sales of its potential blockbuster cancer drug may top out at $500 million -- a fraction of what many people had hoped for – and may see even more disappointing numbers if its direct-to-consumer advertising campaign falls short.
So what's the score? Does this cancer cure have more potential than critics are claiming, and does it have a future with patients who are simply desperate for alternative treatments?
A trial of the company's new drug was so effective that it was stopped early, which bodes well for its final approval.
Updated: 5:54 p.m. ET
A new treatment for prostate cancer was so effective that its clinical trial was halted early, and shares of the developer rocketed Thursday as a result.
Medivation (MDVN) shares saw their biggest intraday percentage spike since December 2004, Bloomberg reports. The stock soared 140.5% to $39.75. Shares closed Wednesday at $16.53.
We're willing to buy companies that report strong quarters only if the news out of Europe is also good.
Surprise? Or no surprise? I am talking about the rate cut Thursday morning in Europe, which signaled to many investors that the new chief central banker, Mario Draghi, is going to try to put out the economic fire while governments deal with the debt issues at hand.
I think it's obvious that we rallied Wednesday because some people knew this was going to happen, so the euphoria quickly died down and we are left with, alas, the ISM report on services in this country, which was disappointing; retail, which was really disappointing; and some earnings reports that were exceptional, like Qualcomm's (QCOM).
Both companies turned out solid earnings that beat estimates, but only one has decidedly bullish charts.
By Tom Aspray, MoneyShow.com
A sharp jump in debit card use helped MasterCard (MA) report a 38% increase in third-quarter earnings Wednesday. The stock closed up 7.3%. Debit card use was up 23%, and company earnings at $5.63 per share were well above the average analyst estimate of $4.81 per share.
MasterCard has outperformed Visa (V) so far this year, but will this continue? Let's take a look at the weekly and daily charts.
A host of disturbing news about consumers is cropping up, and it could mean fewer presents under trees this year.
By Jeff Reeves, InvestorPlace.com
The consumer front hasn't seen many encouraging signs in the past year or so. The big issues remain unresolved: Unemployment is persistently high, housing markets remain battered, and there's a general fear of more hard times to come.
Most investors have become immune to a lot of these major trends, adjusting their expectations to a "new normal" in which the benchmark is significantly less impressive than in previous years. However, just because you've set the bar lower doesn't mean consumers will easily jump over it. A host of disturbing headlines about consumers have cropped up recently, and they could foretell that a rather bleak holiday shopping season.
The social network and the insurance giant are expected to report losses for their most recent quarters.
By Joseph Woelfel, TheStreet
Updated at 8:30 a.m. ET
Social network LinkedIn (LNKD) is expected to post its second quarterly earnings report as a public company. Analysts polled by Thomson Reuters expect a loss of 4 cents a share in quarter ended in September on revenue of $127.6 million.
American International Group (AIG) is expected by analysts to post a quarterly loss of 27 cents a share on revenue of $13.6 billion. On Tuesday, AIG paid back the Treasury Department $972 million of the billions it received in a rescue package from the U.S. government in 2008.
The cult Canadian stock is tapping into American tastes with a new line of cheap espressos and cappucinos.
By Jeff Reeves, InvestorPlace.com
Tim Hortons (THI) is an up-and-coming coffee stock focused mainly on the Midwest and Canada. For 15 straight quarters, sales have beaten totals from the previous year. Shares are up almost 20% in 2011 despite the summer volatility in the stock market. Things are looking up.
With an eye at continuing this kind of growth, Tim Hortons announced this week it will branch out from traditional coffee and pastries into lattes and mochas to appeal to more American tastes.
The brewer reported strong earnings in the third quarter. But will the high share price leave you with a hangover?
Boston Beer (SAM) hopped past analyst expectations with its quarterly earnings and raised full-year guidance significantly, sending shares soaring Wednesday.
The Boston brewer, which makes more than 25 styles of beer, reported third-quarter profit of $1.19 per share on $134.8 million in revenue.
The media conglomerate might be looking at buying the team again -- and that's not in the best interest of shareholders.
Fox Sports, a division of News Corp. (NWSA), may be considering a bid for the L.A. Dodgers.
Fox Sports may participate in an auction for the bankrupt team, according to Bloomberg. But CNBC reports that the division has not explored a bid.
More than half of the company's value comes from its iconic phone, and business could grow significantly as it pushes further into the world's largest mobile market.
China is Apple's (AAPL) fastest-growing region by far.
The company clocked record sales of $4.5 billion there, or 16% of the global total, in its most recent quarter. Revenue in China grew to $13 billion in fiscal 2011, up from about $3 billion, or 2% of total sales, in 2009.
Daily-deals site Groupon is expected to begin trading on Nasdaq by Friday. Will investors go for a price range of $16 to $18?
Groupon, the one-time Internet darling, is expected to price its initial public offering Thursday and get listed on Nasdaq Friday under the symbol GRPN.
The bank isn't giving up more than $1 billion in revenue so easily.
By Dan Freed, TheStreet
Bank of America (BAC) may have backed down from its bid to charge users of its debit cards $5 per month, but if you think that's the end of the bank's attempts to gouge its customers, you are living in a fantasy land.
"Eventually they've got to get that money back," Jefferson Harralson, an analyst at Keefe Bruyette & Woods, told the New York Post for an article published Wednesday. "I think you're going to see other types of fees come up."
A popular component of retirement savings plans, some of these funds are decidedly riskier than others.
By Stan Luxenberg, TheStreet
During the volatile markets of recent months, many target-date funds delivered disappointing results.
When the S&P 500 ($INX) dropped 13.9% in the third quarter, Goldman Sachs Retirement Strategy 2040 (GRNAX) lost 17.7%, while DWS LifeCompass 2040 (TGTAX) declined 17%, according to Morningstar. The showing was especially painful because target-date funds are supposed to protect assets in downturns by holding diversified mixes of stocks and bonds. But not all target-date funds trailed the S&P 500. During the quarter, Invesco Balanced-Risk Retirement 2040 (TNDAX) returned 2.3%, while PIMCO RealRetirement 2040 (POFAX) lost 9.7%.
MORE ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
In this installment of Investor Beat: Best Buy and HHGregg fight to stay alive. And shares of Dow component Home Depot hit an all-time high.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] Stocks ended modestly higher as the S&P 500 climbed 0.2%, and the Dow added 0.4% to register its 19th consecutive Tuesday of gains.
The major averages saw little change during morning action, but afternoon buying interest helped lift the indices to session highs. Most cyclical sectors (with the exception of materials and technology) finished among the leaders, but the defensively-geared health care sector settled atop the leaderboard as biotechnology outperformed. ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|